A novel biomarker TERTmRNA is applicable for early detection of hepatoma
2010 · BMC Gastroenterology · 36 citations
https://doi.org/10.1186/1471-230x-10-46
N
Norimasa Miura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
1.2K
Citations
16
h-index
24
i10-index
Norimasa Miura is an academic researcher from Novartis (Singapore). The author has contributed to research in topics: MicroRNA in disease regulation & RNA Interference and Gene Delivery & Telomeres, Telomerase, and Senescence. The author has an h-index of 16, co-authored 64 publications.
Papers by this author
worksHsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process
2014 · Scientific Reports · 25 citations
https://doi.org/10.1038/srep03852
Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study
2010 · Journal of Translational Medicine · 19 citations
https://doi.org/10.1186/1479-5876-8-103
miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives
2019 · BMC Cancer · 9 citations
https://doi.org/10.1186/s12885-019-5786-y
Hsa-miR-520d-5p promotes survival in human dermal fibroblasts exposed to a lethal dose of UV irradiation
2016 · npj Aging and Mechanisms of Disease · 7 citations
https://doi.org/10.1038/npjamd.2016.29
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat